Liv Hege Dyrnes

Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn.

Utkilen AS operates as a shipping company. The company has in-house functions for chartering, operations, ship management and crewing. The company was founded in 1967 and is headquartered in Bergen, Norway.

Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn.

Torvald Klaveness is a shipping Norwegian company that is focused on safety and uses data to improve the nature of shipping. The private company is based in Oslo, Norway. and has subsidiaries in Singapore. The CEOs of the company are Lasse Kristoffersen, Ernst André Meyer.

Torvald Klaveness is a shipping Norwegian company that is focused on safety and uses data to improve the nature of shipping. The private company is based in Oslo, Norway. and has subsidiaries in Singapore. The CEOs of the company are Lasse Kristoffersen, Ernst André Meyer.

Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn.

Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn.

Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn.

Torvald Klaveness is a shipping Norwegian company that is focused on safety and uses data to improve the nature of shipping. The private company is based in Oslo, Norway. and has subsidiaries in Singapore. The CEOs of the company are Lasse Kristoffersen, Ernst André Meyer.

Torvald Klaveness is a shipping Norwegian company that is focused on safety and uses data to improve the nature of shipping. The private company is based in Oslo, Norway. and has subsidiaries in Singapore. The CEOs of the company are Lasse Kristoffersen, Ernst André Meyer.

Torvald Klaveness is a shipping Norwegian company that is focused on safety and uses data to improve the nature of shipping. The private company is based in Oslo, Norway. and has subsidiaries in Singapore. The CEOs of the company are Lasse Kristoffersen, Ernst André Meyer.

Utkilen AS operates as a shipping company. The company has in-house functions for chartering, operations, ship management and crewing. The company was founded in 1967 and is headquartered in Bergen, Norway.

Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn.

Utkilen AS operates as a shipping company. The company has in-house functions for chartering, operations, ship management and crewing. The company was founded in 1967 and is headquartered in Bergen, Norway.

Utkilen AS operates as a shipping company. The company has in-house functions for chartering, operations, ship management and crewing. The company was founded in 1967 and is headquartered in Bergen, Norway.

Utkilen AS operates as a shipping company. The company has in-house functions for chartering, operations, ship management and crewing. The company was founded in 1967 and is headquartered in Bergen, Norway.

Utkilen AS operates as a shipping company. The company has in-house functions for chartering, operations, ship management and crewing. The company was founded in 1967 and is headquartered in Bergen, Norway.

Utkilen AS operates as a shipping company. The company has in-house functions for chartering, operations, ship management and crewing. The company was founded in 1967 and is headquartered in Bergen, Norway.

Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn.

Utkilen AS operates as a shipping company. The company has in-house functions for chartering, operations, ship management and crewing. The company was founded in 1967 and is headquartered in Bergen, Norway.

Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn.